4//SEC Filing
Fitzgerald Joseph Michael 4
Accession 0001225208-25-006986
CIK 0000885725other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:43 PM ET
Size
9.8 KB
Accession
0001225208-25-006986
Insider Transaction Report
Form 4
Fitzgerald Joseph Michael
SVP & President, Endovascular
Transactions
- Sale
Common Stock
2025-08-01$104.63/sh−50,000$5,231,670→ 178,342 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-01−50,000→ 150,000 totalExercise: $26.15Exp: 2027-12-01→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2025-08-01$26.15/sh+50,000$1,307,500→ 228,342 total
Holdings
- 5,234(indirect: By Children)
Common Stock
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 27, 2025.
- [F2]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.16 to $105.10, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.
- [F4]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on December 1, 2018, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001484186
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 5:43 PM ET
- Size
- 9.8 KB